Category: News

eko.ai raises $4 million in funding, co-led by Sequoia India and EDBI, to automate the fight against heart disease

Singapore, Tuesday 7th January – eko.ai, a fast-growing medtech startup based in Singapore, has raised a $4 million USD round co-led by Sequoia India

Singapore-based EDBI named as Pico investor and strategic partner

NEW YORK, NY – November 13, 2019 – Pico, a leading provider of technology-as-a-service for the financial markets community globally, today announced that EDBI,

EDBI at LTA’s Inaugural Autonomous Mobility Summit 2019

EDBI’s Head of Emerging Technology, Dr Basil Lui on Panel: Investors Perspectives on Autonomous Mobility.

DataRobot Announces $206 Million Series E Funding Round

September 17, 2019 — Boston — DataRobot, the leader in enterprise AI, today announced a $206 million Series E investment round led by Sapphire

Singapore’s EDBI Invests in Cityneon

26 August 2019 – Cityneon Holdings (“Cityneon”, the “Company”/ collectively with its subsidiaries, the “Group”) is pleased to announce EDBI’s investment in Cityneon.

Inari Raises $89 Million to Bring Innovative, Disruptive Technologies to Growers

CAMBRIDGE, MASS. – August 6, 2019 — Inari, the next-generation seed company, today announced the closing of its $89 million Series C financing, bringing

Government-linked strategic investor and leading Silicon Valley investor to Fund Circles.Life Global Ambitions

The latest round came after Circles.Life’s successfully growing subscribers by more than 9X from Q1 2017 to Q1 2019.

Biofourmis Closes USD35M Series B Financing Round to Advance Artificial Intelligence-Powered Digital Therapeutics Platform Funding

Biofourmis Closes $35 Million Series B Financing Round to Advance Artificial Intelligence-Powered Digital Therapeutics Platform

Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer

Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer

ShopBack raises USD45M to power smarter purchase decisions for Asia Pacific consumers

Singapore, 10 April 2019 – ShopBack , the one-stop rewards and discovery platform, has secured US$45M in its latest funding round. New investors include